Jennemann, R., Volz, M., Frias Soler, R. C., Schulze, A., Richter, K., Kaden, S., & Sandhoff, R. (2024). Glucosylceramide synthase inhibition in combination with aripiprazole sensitizes hepatocellular cancer cells to sorafenib and doxorubicin. International journal of molecular sciences, 26(1), . https://doi.org/10.3390/ijms26010304
Chicago-Zitierstil (17. Ausg.)Jennemann, Richard, Martina Volz, Roberto Carlos Frias Soler, Almut Schulze, Karsten Richter, Sylvia Kaden, und Roger Sandhoff. "Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin." International Journal of Molecular Sciences 26, no. 1 (2024). https://doi.org/10.3390/ijms26010304.
MLA-Zitierstil (9. Ausg.)Jennemann, Richard, et al. "Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin." International Journal of Molecular Sciences, vol. 26, no. 1, 2024, https://doi.org/10.3390/ijms26010304.